{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:14:01Z","timestamp":1750220041795,"version":"3.41.0"},"reference-count":24,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2017]]},"DOI":"10.7883\/yoken.jjid.2016.522","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T22:10:34Z","timestamp":1490652634000},"page":"518-521","source":"Crossref","is-referenced-by-count":2,"title":["Surveillance of the Antimicrobial Susceptibility of &lt;i&gt;Neisseria gonorrhoeae&lt;\/i&gt; Isolates Collected in Changsha, China from 2003 to 2015"],"prefix":"10.7883","volume":"70","author":[{"given":"Ting","family":"Peng","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Second Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Second Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinglin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Second Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Second Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Second Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Second Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingli","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Second Xiangya Hospital, Central South University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","unstructured":"1. World Health Organization (WHO). Global incidence and prevalence of selected curable sexually transmitted infections\u20132008. Geneva, Switzerland: WHO; 2012."},{"key":"2","unstructured":"2. Qiu X, Angelia N, Gong X. Reports on syphilis and gonorrhea in China in 2012. Sex Transm Dis. 2013;266:11-21."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bernstein KT, Marcus JL, Nieri G, et al. Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr. 2010;53:537-43.","DOI":"10.1097\/QAI.0b013e3181c3ef29"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Deguchi T, Yasuda M, Maeda S. Lack of nationwide surveillance of antimicrobial resistance of <i>Neisseria gonorrhoeae<\/i> in Japan. Ann Intern Med. 2008;149:363-4.","DOI":"10.7326\/0003-4819-149-5-200809020-00025"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tapsal JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug-and extensively drug-resistant <i>Neisseria gonorrhoeae<\/i>. Expert Rev Anti Infect Ther. 2009;7:821-34.","DOI":"10.1586\/eri.09.63"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Unemo M, Nicholas RA. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 2012;7:1401-22.","DOI":"10.2217\/fmb.12.117"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Unemo M, Shafer WM. Antibiotic resistance in <i>Neisseria gonorrhoeae<\/i>: origin, evolution, and lessons learned for the future. Ann N Y Acad Sci. 2011;1230:E19-28.","DOI":"10.1111\/j.1749-6632.2011.06215.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yokoi S, Deguchi T, Ozawa T, et al. Threat to cefixime treatment for gonorrhea. Emerg Infect Dis. 2007;13:1275-7.","DOI":"10.3201\/eid1308.060948"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Unemo M, Golparian D, Stary A, et al. First <i>Neisseria gonorrhoeae<\/i> strain with resistance to cefixime causing gonorrhoea treatment failure in Austria 2011. Euro Surveill. 2011;16: pii:19998.","DOI":"10.2807\/ese.16.43.19998-en"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lewis DA, Sriruttan C, M\u00fcller EE, et al. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant <i>Neisseria gonorrhoeae<\/i> infection in South Africa and association with cefixime treatment failure. J Antimicrob Chemother. 2013;68:1267-70.","DOI":"10.1093\/jac\/dkt034"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ohnishi M, Golparian D, Shimuta K, et al. Is <i>Neisseria gonorrhoeae<\/i> initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011;55:3538-45.","DOI":"10.1128\/AAC.00325-11"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Unemo M, Golparian D, Nicholas R, et al. High-level cefixime- and ceftriaxone-resistant <i>Neisseria gonorrhoeae<\/i> in France: novel <i>penA<\/i> mosaic allele in a successful international clone causes treatment failure. Antimicrobial Agents Chemother. 2012;56:1273-80.","DOI":"10.1128\/AAC.05760-11"},{"key":"13","unstructured":"13. Kidd S, Kirkcaldy R, Ye T, et al. Cephalosporin-resistant <i>Neisseria gonorrhoeae<\/i> public health response plan. Available at &lt;http:\/\/www.cdc.gov\/std\/treatment\/ceph-r-responseplanjuly30-2012&gt;. Accessed June 11, 2015."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Zheng H, Yang B, Wu X, et al. Antibiotic susceptibility of <i>Neisseria gonorrhoeae<\/i> isolates from Guangzhou, China, during 2002\u20132011. Jpn J Infect Dis. 2014;67:288-91.","DOI":"10.7883\/yoken.67.288"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Su X, Jiang F, Qimuge, et al. Surveillance of antimicrobial susceptibilities in <i>Neisseria gonorrhoeae<\/i> in Nanjing, China, 1999\u20132006. Sex Transm Dis. 2007;34:995-9.","DOI":"10.1097\/OLQ.0b013e3180ca8f24"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gu WM, Chen Y, Yang Y, et al. Twenty-five-year changing pattern of gonococcal antimicrobial susceptibility in Shanghai: surveillance and its impact on treatment guidelines. BMC Infect Dis. 2014;14:731.","DOI":"10.1186\/s12879-014-0731-9"},{"key":"17","unstructured":"17. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial and susceptibility testing: 18th informational supplement. Document M100-S18. Wayne, PA: CLSI; 2008."},{"key":"18","unstructured":"18. CLSI. Performance standards for antimicrobial susceptibility testing: 21st informational supplement. Document M100-S21. 2011;31:92-6."},{"key":"19","unstructured":"19. Zou MX, Xia ZD, Liang XH. Antibiotic susceptibility of <i>Neisseria gonorrhoea<\/i> epidemic strains in Changsha. Hunan Yi Ke Da Xue Xue Bao. 2003;28:53-5. Chinese."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Bala M, Kakran M, Singh V, et al. Members of WHO GASP SEAR Network. Monitoring antimicrobial resistance in <i>Neisseria gonorrhoeae<\/i> in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis. Sex Transm Infect. 2013;89 Suppl 4:28-35.","DOI":"10.1136\/sextrans-2012-050904"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wong HT, Lee KC, Chan DP. Community-based sexually transmitted infection screening and increased detection of pharyngeal and urogenital <i>Chlamydia trachomatis<\/i> and <i>Neisseria gonorrhoeae<\/i> infections in female sex workers in Hong Kong. Sex Transm Dis. 2015;42:185-91.","DOI":"10.1097\/OLQ.0000000000000257"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Unemo M, Golparian D, Skogen V, et al. <i>Neisseria gonorrhoeae<\/i> strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway. Antimicrob Agents Chemother. 2013;57:1057-61.","DOI":"10.1128\/AAC.01775-12"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Martin I, Jayaraman G, Wong T, et al. Canadian Public Health Laboratory Network. Trends in antimicrobial resistance in <i>Neisseria gonorrhoeae<\/i> isolated in Canada: 2000\u20132009. Sex Transm Dis. 2011;38:892-8.","DOI":"10.1097\/OLQ.0b013e31822c664f"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Hottes TS, Lester RT, Hoang LM, et al. Cephalosporin and azithromycin susceptibility in <i>Neisseria gonorrhoeae<\/i> isolates by site of infection, British Columbia, 2006 to 2011. Sex Transm Dis. 2013;40:46-51.","DOI":"10.1097\/OLQ.0b013e31827bd64c"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/70\/5\/70_JJID.2016.522\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T18:06:22Z","timestamp":1750183582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/70\/5\/70_JJID.2016.522\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2016.522","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"type":"print","value":"1344-6304"},{"type":"electronic","value":"1884-2836"}],"subject":[],"published":{"date-parts":[[2017]]}}}